Vijay Pande, founding partner of a16z bio and health strategy, steps down

Coming Partner Vijay Pande in Andreessen Horowitz, who created the company A16Z Bio + health strategy, declared descending from his role.

Since its establishment in 2014, A16Z Bio + Health has raised four funds in the Foundation of about $ 3 billion, including $ 1.5 billion, which was closed in 2022. But now looking for something smaller 750 million a million fifth stockWall Street Journal is reporting. In January, A16Z Bio + said he would handle a health $ 500 million bientech fund Pharmaceutical giant Eli is funded by Lilly.

A16Z supports digital health beginners and companies at the intersection of Bio + Health, AI, computing and biology.

Pande’s investments include healthcare, an individual medical plan provider; Functional health, an individual laboratory test start; And Freemome is a company that aims to discover cancer through blood weight. Before joining Andreessen Horowitz, Pande was a professor of chemistry, structural biology and computer science at Stanford University.

A16Z Bio + Healthcare group, Julie Yoo and Vineeta Agarwala Julie Yoo and Vineeta.